中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 4
Apr.  2016
Turn off MathJax
Article Contents

Efficacy of three liver- protecting drugs commonly used in treatment of drug- induced liver injury: a comparative analysis

DOI: 10.3969/j.issn.1001-5256.2016.04.033
  • Published Date: 2016-04-20
  • Objective To compare the efficacy of three liver- protecting drugs commonly used in the treatment of drug- induced liver injury. Methods The clinical data of 90 patients with drug- induced liver injury who were treated in Yingcheng People's Hospital from November 2012 to April 2015 were analyzed retrospectively,and according to the drugs administered,they were divided into groups A,B,and C,with 30 patients in each group. The patients in groups A,B,and C were treated with reduced glutathione,polyene phosphatidylcholine injection,and tiopronin injection,respectively. The efficacy,drug cost,and incidence of adverse events were compared between the three groups. An analysis of variance was used for comparison of continuous data between multiple groups,and the LSD t- test was used for comparison of continuous data between any two groups; the chi- square test was used for comparison of categorical data between multiple groups.Results Group A had a significantly higher overall response rate than groups B and C( 90. 0% vs 73. 3% /76. 7%,χ~2= 2. 78 and 3. 75,both P < 0. 05). Group B had a significantly higher drug cost than groups A and C( 316. 12 ± 4. 05 RMB vs 235. 13 ± 2. 90 and 135. 21 ±7. 62 RMB,both P < 0. 01). The incidence of adverse events showed no significant differences between the three groups( P > 0. 05). Conclusion In the clinical treatment of drug- induced liver injury,reduced glutathione has better efficacy compared with polyene phosphatidylcholine and tiopronin,as well as a reasonable cost. Therefore,this drug is preferred in the treatment of this disease.

     

  • loading
  • [1]CHEN PR,TAN SY.Influence of a combination of various liverprotecting drugs on incidence of drug-induced liver injury[J].Chin J Tuberc Respir Dis,2014,37(1):58-59.(in Chinese)陈品儒,谭守勇.联合不同种类保肝药物对药物性肝损伤发生率的影响[J].中华结核和呼吸杂志,2014,37(1):58-59.
    [2]TIAN YM,DOU LP,YAO S,et al.Protective effect of ademetionine1,4-butanedisulfonate on liver injury caused by chemotherapeutic agents[J].J Exp Hematol,2013,21(5):1305-1308.(in Chinese)田亚敏,窦丽萍,姚盛,等.S-腺苷蛋氨酸对化疗药物性肝损伤防治疗效的观察[J].中国实验血液学杂志,2013,21(5):1305-1308.
    [3]HAWASA UW,SOLIMAN GM,EL-KASSEM LT,et al.A new flavonoid C-glycoside from solanum elaeagnifolium with hepatoprotective and curative activities against paracetamol-induced liver injury in mice[J].Z Naturforsch C,2013,68(1-2):19-28.
    [4]DU H,TANG Z,GE LH,et al.Cost-effectiveness analysis of 3therapeutic schemes in treating antituberculosis drug-induced hepatotoxicity in HIV/TB patients[J].J Clin Pulm Med,2012,17(8):1430-1432.(in Chinese)杜红,汤卓,葛利辉,等.3种用药方案治疗HIV/TB患者抗结核药物性肝损伤成本-效果分析[J].临床肺科杂志,2012,17(8):1430-1432.
    [5]WU S,YUE Y,TIAN H,et al.Carthamus red from carthamus tinctorius L.exerts antioxidant and hepatoprotective effect against CCl(4)-induced liver damage in rats via the Nrf2 pathway[J].JEthnopharmacol,2013,148(2):570-578.
    [6]HUANG GY,WANG YM.Pharmacoeconomic profiles of four hepatoprotective drugs used for the treatment of drug-induced liver injury[J].Chin J Hepatol,2014,22(10):763-768.(in Chinese)黄广宇,王宇明.四种常用保肝药治疗药物性肝损伤的药物经济学分析[J].中华肝脏病杂志,2014,22(10):763-768.
    [7]LAN D,GAN TQ,WANG L,et al.Value of prophylactic liver-protecting treatment for drug-induced liver injury caused by breast cancer chemotherapy[J].J Guangxi Med Univ,2015,32(2):281-283.(in Chinese)蓝东,甘廷庆,王莉,等.预防性保肝对乳腺癌化疗所致药物性肝损伤的应用价值[J].广西医科大学学报,2015,32(2):281-283.
    [8]DONG Y,HUANG J,LIN X,et al.Hepatoprotective effects of yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice[J].J Ethnopharmacol,2014,152(1):201-206.
    [9]ALI H,KABIR N,MUHAMMAD A,et al.Hautriwaic acid as one of the hepatoprotective constituent of dodonaea viscosa[J].Phytomedicine,2014,21(2):131-140.
    [10]LAI RT,WANG H,GUI HL,et al.Clinical and pathological features in 138 cases of drug-induced liver injury[J].Chin J Hepatol,2012,20(3):185-189.(in Chinese)赖荣陶,王晖,桂红莲,等.138例药物性肝损伤患者的临床特征及肝脏组织学改变[J].中华肝脏病杂志,2012,20(3):185-189.
    [11]ARCHANA PR,VEENA G,SIVARAJ N,et al.Andrographis paniculata(burm.f.)wall.ex nees(kalmegh),a traditional hepatoprotective drug from India[J].Genet Resour Crop Evol,2013,60(3):1181-1189.
    [12]JIN G,LANLAN Z,LI C,et al.Pregnancy outcome following loop electrosurgical excision procedure(LEEP)a systematic review and meta-analysis[J].Arch Gynecol Obstet,2014,289(1):85-99.
    [13]TANG LN,LIN F,SHEN Z,et al.Magnesium isoglycyrrhizinate used in the treatment of chemotherapeutic drugs-induced acute liver dysfunction:a phaseⅢclinical trial[J].Tumor,2012,32(9):738-743.(in Chinese)汤丽娜,林峰,沈赞,等.异甘草酸镁治疗抗肿瘤药物引起的急性药物性肝损伤的Ⅲ期临床试验[J].肿瘤,2012,32(9):738-743.
    [14]HUSSAIN L,IKRAM J,REHMAN K,et al.Hepatoprotective effects of Malva sylvestris L.against paracetamol-induced hepatotoxicity[J].Türksh J Biol,2014,38(3):396-402.
    [15]YANG XY,LI Y,LI ZM,et al.Protective effects of liver protective drugs on liver injury induced by anti-tuberculosis drugs[J].The JPract Med,2015,13:2194-2196.(in Chinese)杨雪迎,李艳,李哲明,等.护肝药物预防抗结核药物所致肝损伤的作用[J].实用医学杂志,2015,13:2194-2196.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (339) PDF downloads(170) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return